Perform Another (Advanced) Search

1. Clinical Trial Results by Drug Names
...Information Title of Study: Relative bioavailability study of ganciclovir from the pro-drug, valganciclovir, in lung transplant recipients with or without cystic fibrosis. Fast Facts: Protocol number: WP18046 Sponsor: Hoffmann-La Roche ...
View Page

2.  Study Posting (4519) Trial #124464, Cytomegalovirus Infections, Pittsburgh, PA
...124464, Cytomegalovirus Infections, Pittsburgh, PA Trial Information A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. Status: Completed Protocol Number: WP18046 Sponsor: Hoffmann-La Roche ...
View Page

3.  Study Posting (4519) Trial #124246, Cytomegalovirus Infections, Cleveland, OH
...124246, Cytomegalovirus Infections, Cleveland, OH Trial Information A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. Status: Completed Protocol Number: WP18046 Sponsor: Hoffmann-La Roche ...
View Page

4.  Study Posting (4519) Trial #123579, Cytomegalovirus Infections, Durham, NC
...123579, Cytomegalovirus Infections, Durham, NC Trial Information A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. Status: Completed Protocol Number: WP18046 Sponsor: Hoffmann-La Roche ...
View Page

5.  Study Posting (4519) Trial #123966, Cytomegalovirus Infections, Los Angeles, CA
...Cytomegalovirus Infections, Los Angeles, CA Trial Information A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. Status: Completed Protocol Number: WP18046 Sponsor: Hoffmann-La Roche ...
View Page

6. Clinical Trial Results by Drug Names
...Names Clinical Trial Result Information Title of Study: A Study of CellCept (Mycophenolate Mofetil) in Lung Transplant Recipients Fast Facts: Protocol number: ML22608 Sponsor: Hoffmann-La Roche Company division: Pharmaceutical Product name ...
View Page

7. Clinical Trial Results: Lung Transplantation
...Date of Report: To be Published Phase: III A Study of CellCept (Mycophenolate Mofetil) in Lung Transplant Recipients Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC. Designed by ...
View Page

8.  CenterWatch: Clinical Trials in Category (682) Cytomegalovirus Infections
...Against Human Cytomegalovirus Los Angeles : Research Site: A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. Los Angeles : Research Site: A Study of Valcyte (Valganciclovir ...
View Page

9.  Study Posting (1570) Trial #156583, Cystic Fibrosis, Morristown, NJ
...least 4 weeks before screening Patient Exclusion Criteria: • Have abnormal renal or liver function • Have lung transplant • Unable to discontinue use of hypertonic saline • Participated in Inspire trial 08-108 Kelly Colucci ...
View Page

10.  Study Posting (2515) Trial #149624, COPD (Chronic Obstructive Pulmonary Disease), Deland, FL
...Current or previous cigarette smoker • COPD diagnosis Patient Exclusion Criteria: • Lung Cancer • Asthma • Lung Surgery • Lung transplant • Lung resection • Lung volume reduction • Active tuberculosis • Cystic Fibrosis Avail Clinical Research, LLC 860 Peachwood ...
View Page

11.  CenterWatch Clinical Research Profile (709) Trial #304, Stanford University School of Medicine, Menlo Park, CA
...the first successful adult human heart transplant in the country and the first combined heart/lung transplant in the world. Stanford Hospital & Clinics is known worldwide for the advanced patient care provided ...
View Page

12. Advanced/Specific Search Results Valcyte [valganciclovir]
...1/2007 Phase: I Relative bioavailability study of ganciclovir from the pro-drug, valganciclovir, in lung transplant recipients with or without cystic fibrosis. Product Name: Valcyte [valganciclovir] Date of Report: 11/30 ...
View Page

13. Clinical Trial Results: Cytomegalovirus infections
...1/2007 Phase: I Relative bioavailability study of ganciclovir from the pro-drug, valganciclovir, in lung transplant recipients with or without cystic fibrosis. Product Name: Valcyte [valganciclovir] Date of Report: 11/30 ...
View Page